Servana (SERV) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
24 Nov, 2025Executive summary
Focused on long-term transition to digital services and AI-based software, with structured efforts to identify acquisition opportunities to strengthen future offerings.
Active dialogues with potential acquisition targets in SaaS and operational businesses for portfolio expansion and scalability.
Revenue remained limited during the period, consistent with the ongoing business transformation.
Financial highlights
Q3 2025 net sales: SEK 6,116; EBITDA: SEK -143,221; result after financial items: SEK -163,076.
Q1–Q3 2025 net sales: SEK 9,790; EBITDA: SEK -2,903,020; result after financial items: SEK -2,942,350.
Modern parent company Q3 2025 net sales: SEK 15,800; EBITDA: SEK -146,694; result after financial items: SEK -146,333.
Group equity as of September 30, 2025: SEK 582,594; parent company equity: SEK 19,329,336.
Cash and cash equivalents at period end: SEK 17,385.
Outlook and guidance
Strategic direction centers on developing acquired platforms, continuous evaluation of strategic acquisitions, and building a scalable portfolio of digital and AI solutions for recurring revenue.
High ambition for the coming year to enable growth and establish a sustainable digital and AI services portfolio.
Latest events from Servana
- Net sales rose and losses narrowed, but equity remains critically low amid ongoing strategic shifts.SERV
Q2 2026 - Net revenue reached SEK 15,330 in Q1 2026, with ongoing digital and AI-driven transformation.SERV
Q1 2026 - Strategic shift to AI and digital services, with negative results but a clear growth focus.SERV
Q4 2025 - Q2 2025 marked a strategic shift to digital and AI, with negative results driven by restructuring.SERV
Q2 2025 - Q3 sales up 27% year-over-year, with Denmark driving growth and expansion capital secured.SERV
Q3 2024 - Medimi to acquire MedThings, boosting Nordic digital medication management and growth.SERV
M&A Announcement - Q2 2024 sales up 30% in Denmark, with improved results and Nordic expansion ongoing.SERV
Q2 2024 - Medimi AB divests core business after Q1 sales growth, shifting focus to a reverse acquisition.SERV
Q1 2025 - Revenue up 32% but restructuring and divestment signal strategic shift.SERV
Q4 2024